Abstract
Both natural and adaptive immune responses were strikingly decreased 2 weeks after injury in 49 spinal cord injuries, 28 tetraplegie and 21 paraplegic patients compared to agematched controls. All values are expressed as means. NK cell function decreased to 21.0% 2 weeks after spinal cord injury compared to 48.6% in controls. At 2 weeks, plasma ACTH values increased to 17.0 pg/ml in patients compared to 11.2 pg/ml in controls and urine free Cortisol levels were elevated to 162.4 μg/24 h in patients compared to 53.6 ug/24 h in controls. T cell function decreased to 40.2% of normal (lymphocyte transformation) by 3 months post injury. T cell activation (IL-2R) was diminished, i.e., 183.4 ug/ml compared to 328.2 ug/ml in controls. With rehabilitation therapy, NK cell function increased to 41.6% by 7 months post injury. NK cell-mediated lysis diminished sharply between 7 and 9 months decreasing to 22.8% at 10 months and ultimately returning to the 2 week post injury level. Rehabilitation therapy contributed to the restoration of T cell function to 92.0% of normal by 6 months post injury where it remained for 6+ months. IL-2R values improved in parallel with lymphocyte transformation. Whereas NK cell-induced lysis remained depressed, i.e., 11.8% at 6 months and 11.4% at 12+ months in patients not receiving therapy, the restoration of NK cell function at 6 months to 40.6% in rehabilitated patients decreased to 23.0% with cessation of treatment. NK cell-mediated lysis values in cervical injury patients were significantly less than those in the thoracic injury group. FIM scores of the two paralleled their NK cell function. With rehabilitation therapy, NK cell-mediated lysis in the cervical group increased from 15.2% to 28.4%, whereas it improved in the thoracic group with therapy from 26.8% to 43.7%. With rehabilitation therapy, lymphocyte transformation in the cervical group increased from 37.3% to 85.6% and improved in the thoracic group from 48.4% to 88.9%. With rehabilitation therapy, FIM scores improved from 49.7 to 74.0 in the cervical group and from 79.8 to 97.3 in thoracic patients compared to 126 in controls of healthy age matched controls.
Similar content being viewed by others
Article PDF
References
Cruse J M et al Neuroendocrine-immune interactions associated with loss and restoration of immune system function in spinal cord injury and stroke patients. Immunol Res 1992; 11: 104–116.
Cruse J M et al Decreased immune reactivity and neuroendocrine alterations related to chronic stress in spinal cord injury and stroke patients. Pathobiology 1993; 61: 183–192.
Uniform Data System for Medical Rehabilitation. SUNY Research Foundation, Buffalo, N. Y., 1992.
Orth D N . Corticotropin Releasing Hormone in Humans. Endocrine Reviews 1992; 13: 164–192.
Irwin, M R, Vale, W and Rivier, C Central corticotropin releasing factor mediates the suppressive effect of footshock stress on natrual cytotoxicity. Endocrin 1990; 126: 2837–2844.
Van de Kar L D, Richardson-Morton, K D, Rittenhouse, P A . Stress: Neuroendocrine and pharmacological mechanisms. In: Jasmin, G., Cantin, M (eds): Stress Revisited. 1. Neuroendocrinology of Stress, Methods Achieve Exp. Pathol., Basel, Karger, 1991; pp. 133–173.
Kort W J, Weijma I M . Chronic stress and the immune response. In: Plotnikoff N, Murgo A, Faith R, Wybran J (eds): Stress and Immunity, CRC Press, Inc., Boca Raton, FL, 1991; pp. 523–536.
Workman E A, La Via M F . Stress and immunity: A behavioral medicine perspective. In: Plotnikoff N, Murgo A, Faith R, Wybran J (eds): Stress and Immunity, CRC Press, Inc., Boca Raton, FL, 1991, pp 69–80.
Felten D L . Central neural circuits involved in neural-immune interactions. In: Plotnikoff N, Murgo A, Faith R, Wybran J (eds): Stress and Immunity, CRC Press Inc., Boca Raton, FL, 1991, pp 3–25.
Weigert D A, Blalock J E . Interactions between the neuroendo crine and immune systems: Common hormones and receptors. Immunol Rev 1987, 100: 79–108.
Felten S Y, Felten D L, Bellinger D L, Olschowka J A . Noradrenergic and peptidergic innervation of lymphoid organs. In: Blalock JE (ed): Neuroimmunoendocrinology., 2nd ed., Chem. Immunol. Basel, Karger, 1992, pp 25–48.
Brodal P . The Central Nervous System, Oxford University Press, 1992, pp 353–354.
Irwin M, Hauger R L, Jones L, Provencio M, Britton K T . Sympathetic nervous system mediates central corticotropin releasing factor induced suppression of natrual killer cytotoxicity. Jour of Pharm Exper Therap 1990, 255: 101–107.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kliesch, W., Cruse, J., Lewis, R. et al. Restoration of depressed immune function in spinal cord injury patients receiving rehabilitation therapy. Spinal Cord 34, 82–90 (1996). https://doi.org/10.1038/sc.1996.14
Issue Date:
DOI: https://doi.org/10.1038/sc.1996.14
Keywords
This article is cited by
-
Natural Killer (NK) Cell Functionality after human Spinal Cord Injury (SCI): protocol of a prospective, longitudinal study
BMC Neurology (2016)
-
Neuroprotective therapy with granulocyte colony-stimulating factor in acute spinal cord injury: a comparison with high-dose methylprednisolone as a historical control
European Spine Journal (2015)
-
Circulating T cell subsets are altered in individuals with chronic spinal cord injury
Immunologic Research (2015)
-
Hot water immersion induces an acute cytokine response in cervical spinal cord injury
European Journal of Applied Physiology (2015)
-
The SCIentinel study - prospective multicenter study to define the spinal cord injury-induced immune depression syndrome (SCI-IDS) - study protocol and interim feasibility data
BMC Neurology (2013)